Soluble TWEAK and Major Adverse Cardiovascular Events in Patients with CKD.

Item

http://www.wikidata.org/entity/Q36686970

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Soluble TWEAK and Major Adverse Cardiovascular Events in Patients with CKD.

@ast

Soluble TWEAK and Major Adverse Cardiovascular Events in Patients with CKD.

@en

type

Item

label

Soluble TWEAK and Major Adverse Cardiovascular Events in Patients with CKD.

@ast

Soluble TWEAK and Major Adverse Cardiovascular Events in Patients with CKD.

@en

prefLabel

Soluble TWEAK and Major Adverse Cardiovascular Events in Patients with CKD.

@ast

Soluble TWEAK and Major Adverse Cardiovascular Events in Patients with CKD.

@en

P1476

Soluble TWEAK and Major Adverse Cardiovascular Events in Patients with CKD

@en

P2093

Angels Betriu

http://www.w3.org/2001/XMLSchema#string

Cristina Sastre

http://www.w3.org/2001/XMLSchema#string

Elvira Fernández

http://www.w3.org/2001/XMLSchema#string

Jesús Egido

http://www.w3.org/2001/XMLSchema#string

Jose L Martín-Ventura

http://www.w3.org/2001/XMLSchema#string

Valvanera Fernández-Laso

http://www.w3.org/2001/XMLSchema#string

P2860

Chronic kidney disease and mortality risk: a systematic review

Fn14 is upregulated in cytokine-stimulated vascular smooth muscle cells and is expressed in human carotid atherosclerotic plaques: modulation by atorvastatin

TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis

Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach

Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk: the ARIC (Atherosclerosis Risk In Communities) study.

A novel role for tumor necrosis factor-like weak inducer of apoptosis (TWEAK) in the development of cardiac dysfunction and failure.

Identification of soluble tumor necrosis factor-like weak inducer of apoptosis (sTWEAK) as a possible biomarker of subclinical atherosclerosis.

Predicting cardiovascular disease morbidity and mortality in chronic kidney disease in Spain. The rationale and design of NEFRONA: a prospective, multicenter, observational cohort study

Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for V

Soluble TWEAK and PTX3 in nondialysis CKD patients: impact on endothelial dysfunction and cardiovascular outcomes.

P304

413-422

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2215/CJN.07900715

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jose M Valdivielso

Luis M Blanco-Colio

P577

2016-01-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26728587

http://www.w3.org/2001/XMLSchema#string

P932

4791813

http://www.w3.org/2001/XMLSchema#string